Cargando…
Positive LGI1 Antibodies in CSF and Relapse Relate to Worse Outcome in Anti-LGI1 Encephalitis
OBJECTIVE: This single-center study was conducted in a cohort of patients with anti-LGI1 encephalitis to investigate the factors related to their functional recovery. METHODS: We retrospectively collected the clinical information of patients admitted to Xuanwu Hospital from January 2014 until Decemb...
Autores principales: | Cui, Li-li, Boltze, Johannes, Zhang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718904/ https://www.ncbi.nlm.nih.gov/pubmed/34975858 http://dx.doi.org/10.3389/fimmu.2021.772096 |
Ejemplares similares
-
Relapses of Anti-NMDAR, Anti-GABABR and Anti-LGI1 Encephalitis: A Retrospective Cohort Study
por: Zhong, Rui, et al.
Publicado: (2022) -
CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis
por: Dürr, Marc, et al.
Publicado: (2021) -
LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018) -
Psychiatric Manifestation of Anti-LGI1 Encephalitis
por: Endres, Dominique, et al.
Publicado: (2020) -
Risk Factors for Mortality in Anti-NMDAR, Anti-LGI1, and Anti-GABABR Encephalitis
por: Zhong, Rui, et al.
Publicado: (2022)